Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 721-729

  Glicksman, Arvin S ^a,d   Wanebo, Harold J ^a   Slotman, Gus ^b   Liu, Li ^a,d   Landmann, Christine ^c   Clark, Jeffrey ^a,e   Zhu, Timothy C ^a,f   Lohri, Andreas ^c   Probst, Rudolf ^c  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d Quality Assurance Review Center   (United States)

^e HARVARD UNIVERSITY   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

Advanced stage head and neck cancer; Trimodality treatment

Indexed keywords

BICARBONATE; CARBOPLATIN; CISPLATIN; DIPHENHYDRAMINE; FLUCONAZOLE; KETOCONAZOLE; PLATINUM DERIVATIVE; RADIOSENSITIZING AGENT;

ADULT; AEROSOL; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL PROTOCOL; CLINICAL TRIAL; DYSPHASIA; ELIXIR; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NUTRITIONAL SUPPORT; PHASE 2 CLINICAL TRIAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; THRUSH; TUMOR BIOPSY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 0030883609     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00366-0     Document Type: Article

References (44)

1. Adelstein, D. J.; Sharan, V. M.; Earle, A. S.; Shah, A. C.; Vlastou, C.; Maria, C. D.; Damm, C.; Carter, S. G.; Hines, J. D. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691; 1990.
2. Barton, M. B.; Keane, T. J.; Gadalla, T.; Maki, E. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer. Radiother. Oncol. 23:51-58; 1992.
3. Beahrs, O., ed. Manual for staging of cancer, 3rd ed. American Joint Committee on Cancer. Philadelphia, PA: J.B. Lippincott; 1992.
4. Begg, A. C.; Hofland, L.; Moonen, H. The predictive value of cell kinetic measurement in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report. Int. J. Radiat. Oncol. Biol. Phys. 19:1449-1453; 1990.
5. Bennet, M.; Wilson, G.; Dische, S.; Saunders, M.; Martindale, C.; O'Halloran, A. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 65:870-878; 1992.
6. Bentzen, S. M.; Thames, H. D. Clinical evidence for tumor clonogen regeneration: Interpretations of the data. Radiother. Oncol. 20:161-166; 1991.
7. Bourhis, J.; Dendale, R.; Hill, C.; Bosq, J.; Janot, F.; Attal, P.; Fortin, A. Marandas, P.; Schwaab, G.; Wibault, P.; Malaise, P. E.; Bobin, S.; Luboinski, B.; Eschwege, F.; Wilson, G. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks. Int. J. Radiat. Oncol. Biol. Phys. 35:471-476; 1996.
8. Bourhis, J.; Wilson, G.; Wibault, P.; Bosq, J.; Chavaudra, N.; Janot, F.; Luboinski, B.; Eschwege, F.; Malaise, E. P. In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26:793-799; 1993.
9. Coughlin, C. T.; Richmond, R. C. Biologic and clinical developments of cisplatin combined with radiation: Concepts, utility, projections for new trials, and the emergence of carboplatin. Semin. Oncol. 16 (Suppl. 6):31-38; 1989.
10. Crissman, J. D.; Pajak, T. F.; Zarbo, R. J. Marcial, V. A.; Al-Sarraf, M. Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. Cancer 59:1391-1397; 1987.
11. Duncan, W.; Orr, J. A.; Arnott, S. J. Jack, W. J.; Kerr, G. R.; Williams, J. R. Fast neutron therapy for squamous cell carcinoma in the head and neck region: Results of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 13:171-178; 1987.
12. Flentje, M.; Eble, M.; Haner, U.; Trinh, S.; Wannenmacher, M. Additive effects of cisplatin and radiation in human tumor cells under oxic. Radiother. Oncol. 24:60-63; 1992.
13. Forastiere, A. A.; Perry, D. J.; Wolf, G. T. Cisplatin and mitoguazone: An induction chemotherapy regimen in advanced head and neck cancer. Cancer 62:2304-2308; 1988.
14. Fowler, J. F. Potential for increasing the differential response between tumors and normal tissues: Can proliferation rate be used? Int. J. Radiat. Oncol. Biol. Phys. 12:641-645; 1986.
15. Fowler, J. F. Review articles - the linear-quacratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62: 679-694; 1989.
16. Fowler, J. F.; Lindstrom, M. J. Loss of local control with prolongation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 23:457-467; 1992.
17. Fu, K. K.; Phillips, T. L. Biologic rationale of combined radiotherapy and chemotherapy. Hematol. Oncol. Clin. North Am. 5:737-745; 1991.
18. Glicksman, A. S.; Slotman, G.; Doolittle, C. III, Clark, J.; Koness, J.; Coachman, N.; Posner, M.; DeRosa, E.; Wanebo, H. Concurrent cis-platinum with or without surgery for advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 30:1043-1050; 1994.
19. Griffin, T. W.; Davis, R.; Laramore, G. E. Fast neutron irradiation of metastatic cervical adenopathy: The results of a randomized RTOG study. Int. J. Radiat. Oncol. Biol. Phys. 9:1267-1270; 1983.
20. Haselow, R. E.; Adams, G. L.; Oken, M. M. Cisplatinum (DDP) with radiation therapy (RT) for locally unresectable head and neck cancer. Proc. Am. Soc. Clin. Oncol. 2:169; 1983.
21. Jesse, R. H.; Fletcher, G. H. Treatment of neck in patients with squamous cell carcinoma of the head and neck. Cancer 39: 868-872; 1977.
22. Johnson, J. T.; Myers, E. N.; Schramm, V. L., Jr.; Mayernik. D. G.; Nolan, T. A.; Sigler, B. A.; Wagner, R. L. Adjuvant chemotherapy for high-risk squamous cell carcinoma of the head and neck. J. Clin. Oncol. 5:456-458; 1987.
23. Kramer, S.; Gelber, R. D. Snow, J. B.; et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg. 10:19-30; 1987.
24. Lustig, R.; McIntosh-Lowe, N.; Rose, C.; Haas, J.; Krasnow, S.; spaulding, M.; Prosnitz, L. Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck. Int J. Radiat. Oncol. Biol. Phys. 16:1587-1593; 1989.
25. Merlano, M.; Vitale, V.; Rosso, R.; Benasso, M.; Corvo, R.; Cavallari, M.; Sanguinetti, G.; Bacigalupo, A.; Badellino, F.; Margarino, G. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N. Engl. J. Med. 327:9115-9121; 1992.
26. Mohit-Tabatabai, M, A.; Rush, B.F.; Hill, G. J. Multimodality preoperative treatment advanced cancer of the head and neck. Am. J. Surg. 148:521-524; 1984.
27. Pajak, T. F.; Laramore, G. E.; Marcial, V. A. Elapsed treatment days-A critical item for tadiotherapy quality control review in head and neck trials. RTOG report. Int. J. Radiat. Oncol. Biol. Phys. 20:13-20; 1991.
28. Parsons, J. T.; Mendenhall, W. M.; Cassisi, N. J.; Isaacs, J. H., Jr.; Million, R. R. Hyperfractionation for head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 14:649-668; 1988.
29. Schwachofer, J. H. M.; Crooijmans, R. P. M. A.; Hoogenhout, J.; Kal, H. B.; Theeuw G. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin. Influence of treatment sequence. Int. J. Radiat. Oncol. Biol. Phys. 20:1235-1241; 1990.
30. Slotman, G. J.; Cummings, F. J.; Glicksman, A. S.; Doolittle, C. L.; Leone, L. A. Preoperative simultaneously administered cis-platinum cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck. Cancer 59: 1391-1397; 1987.
31. Skladowski, K.; Law, M. G.; Maciejewski, B.; Steel, G. G. Planned and unplanned gaps in radiotherapy: The importance of gap position and gap duration. Radiother. Oncol. 30:109-120; 1994.
32. Taylor, S. G.; Murphy, A. K.; Caldarelli, D. D.; Showel, J. L.; Kiel, K.; Griem, K. L.; Mittal, B. B.; Kies, M.; Hutchinson, J. C., Jr.; Holinger, L. D. Combined simultaneous cisplatin/ fluorouracil chemotherapy and split course radiation in head and neck cancer. J. Clin. Oncol. 7:846-856; 1989.
33. Trott, K. R. Cell repopulation and overall treatment time. Int. J. Radiat. Oncol. Biol. Phys. 19:1071-1075; 1990.
34. Trott, K.-R.; Kummermehr, K. What is known about tumour proloferation rates to choose between accelerated fractionation or hyperfractionation? Radiother. Oncol. 3:1-10; 1985.
35. Vikram, B.; Strong, E. W.; Shah, J. Elective postoperative radiation therapy in Stages III and IV epidermoid carcinoma of the head and neck. Am. J. Surg. 140:580-584; 1980.
36. Vokes, E. E.; Panje, W. R.; Mick, R.; Kozloff, M. F.; Moran, W. J.; Sutton, H. G.; Goldman, M. D.; Tybor, A. G.; Weichselbaum, R. R. A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer. Cancer 66:206-213; 1990.
37. Wanebo, H. J.; Glicksman, A. S.; Landmann, C.; Slotman, G.; Doolettle, C.; Clark, J.; Koness, R. J. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer. Am. J. Surg. 170:512-516; 1995.
38. Wang, C. C. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int. J. Radiat. Oncol. Biol. Phys. 14:1143-1146; 1988.
39. Weichselbaum, R. R.; Rotmensch, J.; Ahmed-Swan, S.; Beckett, M. A. Radiobiological characterization of 53 human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 56:553-560; 1989.
40. Wessberg, J. B.; Son, Y. H. Papac, R. J.; Saski, C.; Fischer, D. B.; Lawrence, R.; Rockwell, S.; Sartorelli, A. C.; Fischer, J. J. Randomized clinical trial of mitomycin as an adjunct to radiotherapy in head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 17:3-9; 1989 .
41. Wilson, G. D.; McNally, N. J.; Dische, S.; Bennet, M. Cell proliferation in human tumours measured by in vivo labeling with bromodiosyuridine. Br. J. Cancer 58:423-431; 1988.
42. Withers, H. R.; Taylor, J. M. G.; Maciejewski, B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.
43. Wong, W. W.; Mick, R.; Haraf, D. J.; Weichselbaum, R. R.; Vokes, E. E. Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. J. Radiat. Oncol. Biol. Phys. 29:153-162; 1995.
44. Yang, L. X.; Douple, E. B.; Wang, H. J. Irradiation enhances cellular uptake of carboplatin. Int. J. Radiat. Oncol. Biol. Phys. 33:641-646; 1995.